Other

Exercise price, percentage of fair market value at grant date, minimum

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2026
Last reportedQ1 2026
Metric ID: other_share_based_compensation_arrangement_by_share_base_8cb720

Historical Data

1 periods
 Q1 '26
Value1

Frequently Asked Questions

What is Veradermics 's exercise price, percentage of fair market value at grant date, minimum?
Veradermics (MANE) reported exercise price, percentage of fair market value at grant date, minimum of $1.00 in Q1 2026.